ODTX
Odyssey Therapeutics, Inc.
20.70$
+1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | -10,870.6% | -2,626.8% | -4,350.4% | |
| – | 473.3% | 116.1% | 165.0% | |
| – | 603.8% | 194.2% | 481.3% | |
| – | 86.4% | -73.9% | -158.9% | |
| – | 487.6% | 17.1% | 41.4% | |
| – | – | – | -3,492.7% | |
| – | -458.9% | – | – | |
| – | 8,879.1% | 603.3% | 7,246.2% | |
| – | -17,904.2% | 141.8% | -586.3% | |
| – | -11,358.1% | -2,643.9% | -4,391.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.